If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
Description
Anti-Human DR5 Therapeutic Antibody (Conatumumab). Recombinant monoclonal antibody to DR5. Conatumumab (originally AMG 655) is a monoclonal antibody developed for the treatment of cancer. it is a fully human monoclonal agonist antibody directed against the extracellular domain of human TRAIL (tumor necrosSuitable for use in Neut, ELISA, IF, IP, FuncS, FC, ICC and most other immunological methods.
Immunogen
n/a
Other Names
Conatumumab;896731-82-1;AMG 655;XG1-048;TRAIL-R2 mAb;AMG 655;TNFRSF10B;tumor necrosis factor receptor superfamily, member 10b;tumor necrosis factor receptor superfamily member 10B;CD262;DR5;KILLER;TRAIL R2;TRICK2A;TRICKB;Fas-like protein;death receptor 5;